TERRACCIANO, DANIELA
 Distribuzione geografica
Continente #
AS - Asia 8.356
NA - Nord America 6.574
EU - Europa 5.688
SA - Sud America 970
AF - Africa 265
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.866
Nazione #
US - Stati Uniti d'America 6.273
SG - Singapore 3.453
RU - Federazione Russa 2.567
VN - Vietnam 1.831
CN - Cina 1.552
IT - Italia 1.205
BR - Brasile 748
HK - Hong Kong 554
DE - Germania 424
FR - Francia 268
NL - Olanda 261
FI - Finlandia 219
GB - Regno Unito 219
IN - India 205
JP - Giappone 154
CA - Canada 137
KR - Corea 104
UA - Ucraina 104
MX - Messico 102
AR - Argentina 92
CI - Costa d'Avorio 81
IE - Irlanda 81
BD - Bangladesh 78
SE - Svezia 68
PL - Polonia 66
PH - Filippine 63
ZA - Sudafrica 54
TH - Thailandia 52
IQ - Iraq 51
ES - Italia 47
ID - Indonesia 39
TR - Turchia 36
AT - Austria 33
NG - Nigeria 33
EC - Ecuador 29
PK - Pakistan 26
CO - Colombia 25
LT - Lituania 24
TW - Taiwan 20
JO - Giordania 18
KE - Kenya 18
PY - Paraguay 18
VE - Venezuela 18
CL - Cile 14
UZ - Uzbekistan 14
CZ - Repubblica Ceca 13
DK - Danimarca 13
EG - Egitto 13
TN - Tunisia 13
PE - Perù 12
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
BE - Belgio 9
MA - Marocco 9
NP - Nepal 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
IL - Israele 8
JM - Giamaica 8
MY - Malesia 8
SA - Arabia Saudita 8
CH - Svizzera 7
IR - Iran 7
RO - Romania 7
BG - Bulgaria 6
CR - Costa Rica 6
DZ - Algeria 6
GR - Grecia 6
LV - Lettonia 6
PT - Portogallo 6
RS - Serbia 6
ET - Etiopia 5
GA - Gabon 5
HN - Honduras 5
LC - Santa Lucia 5
PA - Panama 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
NI - Nicaragua 4
OM - Oman 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
GE - Georgia 3
GM - Gambi 3
GT - Guatemala 3
KG - Kirghizistan 3
KH - Cambogia 3
KZ - Kazakistan 3
NA - Namibia 3
NZ - Nuova Zelanda 3
BH - Bahrain 2
BS - Bahamas 2
Totale 21.807
Città #
Singapore 1.744
San Jose 1.224
Ashburn 711
Moscow 543
Hong Kong 525
Chandler 490
Beijing 471
Ho Chi Minh City 466
Hanoi 400
Naples 391
Hefei 378
Santa Clara 271
Amsterdam 205
Los Angeles 201
Munich 177
Lauterbourg 168
Dong Ket 148
Dallas 136
Tokyo 127
New York 120
The Dalles 116
Millbury 97
Boston 95
Napoli 91
Da Nang 83
São Paulo 82
Council Bluffs 77
Jacksonville 76
Redondo Beach 72
Seoul 70
Turku 70
Haiphong 66
Buffalo 61
Orem 61
Des Moines 60
Princeton 60
Helsinki 58
Lawrence 58
Warsaw 55
Frankfurt am Main 54
Nanjing 54
Mexico City 52
Rome 51
Wilmington 50
London 48
Milan 45
Kochi 44
Montreal 44
Seattle 43
Chennai 42
Boardman 41
Brooklyn 41
Chicago 41
Denver 38
Lappeenranta 38
Phoenix 36
Houston 35
Ottawa 34
Poplar 34
Nuremberg 32
Abuja 31
Biên Hòa 29
Atlanta 28
Johannesburg 28
Baghdad 24
Casamassima 24
Bari 23
Woodbridge 22
Brasília 21
Can Tho 21
Dearborn 21
Düsseldorf 21
Rio de Janeiro 21
Stockholm 21
Hải Dương 20
Toronto 20
Bangkok 19
Dublin 19
Falkenstein 19
Washington 19
Ankara 18
Tianjin 18
Nanchang 17
Amman 16
Curitiba 16
Guangzhou 16
Ninh Bình 16
Fairfield 15
Hebei 15
Manchester 15
Nairobi 15
Pune 15
Querétaro 15
Vienna 15
Bắc Giang 14
Changsha 14
Mumbai 14
Norwalk 13
Shenyang 13
Campinas 12
Totale 11.954
Nome #
The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota 218
System for the automated sanitization of containers for biological samples and its process of use 198
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 193
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 191
Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report 191
HNP-1 and HBD-1 as biomarkers for the immune systems of elite basketball athletes 177
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis 173
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 170
Sistema per la sanificazione automatizzata di contenitori per campioni biologici e suo procedimento di utilizzo 169
New approaches in the diagnostic procedure of malignant pleural effusions 169
Analysis of glycoproteins in human colon cancers, normal tissues and in human colon carcinoma cells reactive with monoclonal antibody NCL-19-9 168
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40 167
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 167
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 165
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 164
Laboratory medicine: health evaluation in elite athletes 162
A MOUSE MODEL DEMONSTRATES A MULTIGENIC ORIGIN OF CONGENITAL HYPOTHYROIDISM 159
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA 158
Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL 156
Athlete's Passport: Prevention of Infections, Inflammations, Injuries and Cardiovascular Diseases 155
alpha1(I) collagen gene expression in quail epiphyseal chondrocytes. 154
Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report 154
Cyclic AMP-dependent secretion of Ca 19-9 by LS 174T human colon carcinoma cells 153
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 152
Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs 152
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 151
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 150
Thyroid Hormone Regulates the Lipid Content of Muscle Fibers, Thus Affecting Physical Exercise Performance 149
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 149
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 149
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats 148
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 148
Iodine status assessment in Campania (Italy) as determined by urinary iodine excretion. 147
Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase 146
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions. 146
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 146
Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19 145
Identification of serum biomarkers for the prevention of inflammation, infection, muscle injuries and cardiovascular disease in competitive athletes 145
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 145
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content. 145
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 145
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 145
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors 144
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis 144
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine 144
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 144
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 143
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. 142
Biomarkers in localized prostate cancer 142
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 141
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 141
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 141
Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors. 140
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 140
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 139
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 139
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 139
Expression of Lewis carbohydrate antigen in human tumors. 138
Liquid biopsy in bladder cancer: State of the art and future perspectives 138
Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. 137
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 137
Beyond PSA: The Role of Prostate Health Index (phi) 137
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 137
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients 137
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis 134
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 134
Diagnostic value of carbohydrate antigens in supernatantsand sediments of pleural effusions 134
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 134
Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue 134
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 134
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor 132
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome. 131
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 131
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 131
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 131
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 130
Human defensins: Potential role in the Immune System of Professional Basketball Athletes 130
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 129
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 129
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis 128
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 128
Childhood obesity: an overview of laboratory medicine, exercise and microbiome 128
Rhes is involved in strial function 127
Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formation. 126
Thyrotropin (tsh) directly and acutely affects vascular reactivity in humans 126
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 126
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 126
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 125
Prostate cancer radiogenomics—from imaging to molecular characterization 125
INSULIN RESISTANCE (IR) AND PROSTATE CANCER (PCa): THE EFFECT OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY ON IR IN PATIENTS WITH A DIAGNOSIS OF PCa 124
Identification of genes controlled by the Foxe 1 transcription factor 124
Salvage radical prostatectomy after external beam radiation therapy: A systematic review of current approaches 124
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 124
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model 124
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 123
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status 123
Enhancement of vascular endothelial function by recombinant human thyrotropin 122
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform 122
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 122
The emerging role of obesity, diet and lipid metabolism in prostate cancer 121
Totale 14.414
Categoria #
all - tutte 63.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021228 0 0 0 0 0 0 0 0 0 27 35 166
2021/2022856 18 12 11 3 21 12 24 31 86 83 262 293
2022/20231.267 140 102 48 59 148 138 16 126 183 197 83 27
2023/20241.081 38 134 206 112 69 95 18 132 27 23 148 79
2024/20255.601 206 220 12 67 214 290 539 336 395 601 2.249 472
2025/202612.207 1.242 1.014 1.361 1.376 2.099 554 1.486 716 1.580 779 0 0
Totale 22.195